The proliferation of thyroid cancer cells induced by ALK fusions in vitro and in nude mice was blocked by crizotinib and TAE684 (ALK inhibitors), which indicated ALK fusions as a potential therapeutic target of thyroid carcinomas (32). Here, ALK is linked to thyroid gland carcinoma.